Optineurin restrains IL-17–associated neuroinflammation in trigeminal ganglia to preserve sensory function after ocular HSV-1 infection
The Journal of Immunology · 2026
DOI: 10.1093/jimmun/vkag161 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2026. Verfasst von Joshua Ames und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology and Visual Sciences, College of Medicine, University of Illinois Chicago, Chicago, IL, United States. Hauptthemen laut MEDLINE: Trigeminal Ganglion, Interleukin-17, Herpesvirus 1, Human, Membrane Transport Proteins. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Neurotrophic keratitis (NK) arises when trigeminal sensory dysfunction reduces corneal sensation and compromises epithelial maintenance. Herpes simplex virus type 1 (HSV-1) establishes latency in the trigeminal ganglion (TG) and is a common trigger of acquired NK, yet the host programs that determine whether inflamed ganglia recover or degenerate remain poorly defined. Moreover, experimental models that faithfully capture NK-like neuroimmune pathology are limited. Using a murine ocular HSV-1 infection model, we identify optineurin (OPTN) as a key regulator of trigeminal nerve preservation. Optn−/− mice developed severe corneal opacity and rapid, persistent loss of corneal and whisker sensitivity despite comparable corneal viral titers. Droplet-based single-cell RNA sequencing of TGs at 30 days postinfection revealed reduced recovery of peripheral neuronal transcriptomes and coordinated enrichment of chemokine/NF-κB and Th17/IL-17 gene signatures across neurons, endothelial cells, and myeloid/lymphoid populations. Consistent with these transcriptional programs, IL-17 was elevated in Optn−/− TGs at 30 days, whereas the cornea and draining lymph nodes did not exhibit increased IL-17 production early after infection. Neuronal staining demonstrated loss of the synaptic marker SNCG without increased neuronal death, implicating IL-17–associated inflammation in neuronal dysfunction rather than acute ablation. Together, these findings identify OPTN as a neuroimmune checkpoint that restrains chronic IL-17–linked ganglionic inflammation to preserve sensory function and suggest that OPTN deficiency provides a tractable experimental model for studying HSV-associated NK.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology and Visual Sciences, College of Medicine, University of Illinois Chicago, Chicago, IL, United States.
- Department of Microbiology and Immunology, College of Medicine, University of Illinois Chicago, Chicago, IL, United States.
- Department of Immunology, University of Washington, Seattle, WA, United States.
ORCID-Profile: Joshua Ames, Tejabhiram Yadavalli, Chandrashekhar Patil, Deepak Shukla
Förderung
- NEI NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Ames, J., Kadam, R., Yadavalli, T., Patil, C., Bhattacharya, I., & Shukla, D. (2026). Optineurin restrains IL-17–associated neuroinflammation in trigeminal ganglia to preserve sensory function after ocular HSV-1 infection. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkag161
Vancouver
Ames J, Kadam R, Yadavalli T, Patil C, Bhattacharya I, Shukla D. Optineurin restrains IL-17–associated neuroinflammation in trigeminal ganglia to preserve sensory function after ocular HSV-1 infection. The Journal of Immunology. 2026. doi:10.1093/jimmun/vkag161
BibTeX
@article{Ames2026,
author = {Ames, Joshua and Kadam, Rashmi and Yadavalli, Tejabhiram and Patil, Chandrashekhar and Bhattacharya, Ilina and Shukla, Deepak},
title = {Optineurin restrains IL-17–associated neuroinflammation in trigeminal ganglia to preserve sensory function after ocular HSV-1 infection},
journal = {The Journal of Immunology},
year = {2026},
doi = {10.1093/jimmun/vkag161}
}
EUVIMED